Skip to content
The Colorado Prescription Drug Affordability Board (PDAB) has many patients, patient advocacy groups, and bioscience organizations in the state worried. As one of the […]
Colorado PDAB could limit patient access to medicines Read More »
During the State of the Union address on March 7, President Biden said, “Women are more than half of our population, but research on
BIO’s Women’s Health Task Force fosters greater innovation in women’s health Read More »
As fashion weeks in both the U.S. and Europe come to a close, it begs the question of staying fashionable and environmentally friendly. In
Biotech fashion takes naturally sourced textiles literally Read More »
Mergers and acquisitions (M&A) are important elements of the biotech industry, especially for early-stage fundraising and bringing new drugs and treatments to the market.
What biotech companies should know about M&A in down markets Read More »
The metabolic field is the hottest biotech therapeutic area of the year (and likely to continue beyond). In the context of a difficult couple
The future of next-generation obesity drugs Read More »
The biotech industry must constantly navigate the ins and outs of Beltway politics. During an election year, the need to anticipate and plan for
What policy biotech should be watching this election year Read More »
The Biotechnology Innovations Organization (BIO) report, The State of Innovation in Vaccines and Prophylactic Antibodies for Infectious Diseases, on January 25, 2024, found that
CEOs explore challenges and opportunities in vaccine pipeline Read More »
On February 21, the Biotechnology Innovation Organization’s (BIO) soon-to-be President & CEO, John F. Crowley, joined an event about biomarkers and rare disease regulatory
How biomarkers can support regulatory rare disease pathways Read More »
AstraZeneca recently announced that it is investing $300 million in a Rockville, MD facility “to launch its life-saving cell therapy platforms in the US
AstraZeneca announces new $300 million Maryland facility Read More »
GSK believes that “innovation starts when we stop to listen.” In 2023, GSK took a moment to engage with a variety of people across
GSK survey shows optimism for the future of biotech innovation Read More »
